Moderna, Inc. (MRNA) Shareholders’ equity 2016–2025
Moderna, Inc. (MRNA) shareholders’ equity at each fiscal year-end, per SEC filings.
$8.7BFY2025 · since FY2016: -$334.8M → $8.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.7B | -20.6% |
| FY2024 | $10.9B | -21.3% |
| FY2023 | $13.9B | -27.6% |
| FY2022 | $19.1B | +35.2% |
| FY2021 | $14.1B | +452.3% |
| FY2020 | $2.6B | +118.0% |
| FY2019 | $1.2B | -23.2% |
| FY2018 | $1.5B | +377.5% |
| FY2017 | -$551.4M | -64.7% |
| FY2016 | -$334.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice